China-based Pharmaron, a fully integrated contract research organization (CRO) offering R&D services, has acquired Xceleron, a Maryland, U.S.-based accelerator mass spectrometry (AMS) specialist for life sciences. The AMS platform developed at Xceleron has unique sensitivity and features that allows identification and analysis of therapeutically and biologically relevant entities, including small molecules to large molecules at low concentrations. With this, Xceleron has supported regulat...